Status:

COMPLETED

Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound

Lead Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions:

Prostate Cancer

Adenocarcinoma of the Prostate

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to assess the performance of a system of intraoperative dynamic dosimetry during prostate seed implantation (brachytherapy) including its new elements, to evaluate and ref...

Detailed Description

The use of brachytherapy or implantation of radioactive sources into the prostate for adenocarcinoma has advantages over external beam radiation in that a very high dose can be delivered to the tumor ...

Eligibility Criteria

Inclusion

  • Histologically confirmed, localized adenocarcinoma of the prostate
  • Clinical stages T1b - T3a
  • The patient has decided to undergo brachytherapy (or brachytherapy plus external beam radiation) as a treatment modality for his prostate cancer
  • Karnofsky Performance Status \> 60
  • Prostate volume by transrectal ultrasound (TRUS) \< 55 cc
  • International Prostate symptom score (IPSS) 20 or less
  • Ability to have Magnetic resonance imaging as part of post-implant assessment
  • Signed study-specific consent form prior to registration

Exclusion

  • Stage T3b or greater disease.
  • Prior history of pelvic radiation therapy
  • Significant obstructive symptoms (IPSS greater than 20)
  • Major medical or psychiatric illness which, in the investigator's opinion, would prevent completion of treatment and would interfere with follow up.
  • Implanted device or apparatus which obstruct visibility of the implanted sources on fluoroscopy
  • Metallic implants, claustrophobia not amenable to medication, or known contraindications to undergoing MR scanning

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2023

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT02225925

Start Date

October 1 2014

End Date

February 28 2023

Last Update

March 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The SKCCC at Johns Hopkins

Baltimore, Maryland, United States, 21287